Publications

Pneumococcal glycoconjugate vaccines produce antibody responses that strongly correlate with function.

Licciardi, PV; Balloch, A; Russell, FM; Nahm, MH; MULHOLLAND, K; Tang, ML K;

2011

Nature reviews Drug discovery, (2011).10 5 10.1038/nrd3012-c1.

The impacts of measles elimination activities on immunization services and health systems in six countries.

Hanvoravongchai, P; MOUNIER-JACK, S; Cruz, VO; BALABANOVA, D; Biellik, R; Kitaw, Y; Koehlmoos, T; Loureiro, S; Molla, M; Nguyen, HT; Ongolo-Zogo, P; Sadykova, U; Sarma, H; Teixeira, MG; Uddin, J; Dabbagh, A; Griffiths, UK;

2011

Disease Eradication in the 21st Century: Implications for Global Health (2011).

Vaccines and global health.

GREENWOOD, B; Salisbury, D; Hill, AV S;

2011

Philosophical transactions of the Royal Society of London Series B, Biological sciences, (2011).366 1579 10.1098/rstb.2011.0076.

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.

Ansong, D; ASANTE, KP; Vekemans, J; Owusu, SK; Owusu, R; Brobby, NA W; DOSOO, D; Osei-Akoto, A; Osei-Kwakye, K; Asafo-Adjei, E; Boahen, KO; Sylverken, J; Adjei, G; Sambian, D; Apanga, S; Kayan, K; Janssens, MH; Lievens, MJ J; Olivier, AC; Jongert, E; Dubois, P; Savarese, BM; Cohen, J; Antwi, S; GREENWOOD, BM; ... OWUSU-AGYEI, S.

2011

PloS one, (2011).6 4 10.1371/journal.pone.0018891.

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.

McLellan, JS; Pancera, M; Carrico, C; Gorman, J; Julien, J-P; Khayat, R; Louder, R; Pejchal, R; Sastry, M; Dai, K; O'Dell, S; Patel, N; Shahzad-ul-Hussan, S; Yang, Y; Zhang, B; Zhou, T; Zhu, J; Boyington, JC; Chuang, G-Y; Diwanji, D; Georgiev, I; Kwon, YD; Lee, D; Louder, MK; Moquin, S; ... Kwong, PD.

2011

Nature, (2011).480 7377 10.1038/nature10696.

Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.

Tilson, L; JIT, M; Schmitz, S; Walsh, C; Garvey, P; McKeown, P; Barry, M;

2011

Vaccine, (2011).29 43 10.1016/j.vaccine.2011.07.056.

Mathematical models in the evaluation of health programmes.

Garnett, GP; COUSENS, S; Hallett, TB; Steketee, R; Walker, N;

2011

Lancet, (2011).378 9790 10.1016/S0140-6736(10)61505-X.

A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1.

TETTEH, KK A; CONWAY, DJ;

2011

Vaccine, (2011).29 44 10.1016/j.vaccine.2011.07.106.

Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial.

ROCA, A; Hill, PC; Townend, J; Egere, U; ANTONIO, M; BOJANG, A; Akisanya, A; Litchfield, T; Nsekpong, DE; Oluwalana, C; Howie, SR C; GREENWOOD, B; Adegbola, RA;

2011

PLoS medicine, (2011).8 10 10.1371/journal.pmed.1001107.

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.

Ibarz-Pavón, AB; Maclennan, J; Andrews, NJ; Gray, SJ; Urwin, R; Clarke, SC; Walker, AM; Evans, MR; Kroll, JS; Neal, KR; Ala'aldeen, D; Crook, DW; Cann, K; Harrison, S; Cunningham, R; Baxter, D; Kaczmarski, E; McCarthy, ND; Jolley, KA; Cameron, JC; STUART, JM; Maiden, MC J;

2011

The Journal of infectious diseases, (2011).204 7 10.1093/infdis/jir466.